Dehydroascorbic acid (DHA), the first stable oxidation product of vitamin C
, was transported by GLUT1 and GLUT3 in Xenopus laevis oocytes with transpo
rt rates similar to that of P-deoxyglucose (2-DG), but due to inherent diff
iculties with GLUT4 expression in oocytes it was uncertain whether GLUT4 tr
ansported DHA (Rumsey, S, C., Kwon, O., Xu, G. W., Burant, C. F., Simpson,
I., and Levine, M. (1997) J. Biol. Chem. 272, 18982-18989). We therefore st
udied DHA and 2-DG transport in rat adipocytes, which express GLUT4. Withou
t insulin, rat adipocytes transported 2-DG 2-3-fold faster than DHA. Preinc
ubation with insulin (0.67 mu M) increased transport of each substrate simi
larly: 7-10-fold for 2-DG and 6-8-fold for DHA, Because intracellular reduc
tion of DHA in adipocytes was complete before and after insulin stimulation
, increased transport of DHA was not explained by increased internal reduct
ion of DHA to ascorbate, To determine apparent transport kinetics of GLUT4
for DHA, GLUT4 expression in Xenopus oocytes was reexamined. Preincubation
of oocytes for >4 h with insulin (1 mu M) augmented GLUT4 transport of 2-DG
and DKA by up to 5-fold. Transport of both substrates was inhibited by cyt
ochalasin B and displayed saturable kinetics. GLUT4 had a higher apparent t
ransport affinity (K-m of 0.98 versus 5.2 mM) and lower maximal transport r
ate (V-max of 66 versus 880 pmol/oocyte/10 min) for DHA compared with 2-DG.
The lower transport rate for DHA could not be explained by binding differe
nces at the outer membrane face, as shown by inhibition with ethylidene glu
cose, or by transporter trans-activation and therefore was probably due to
substrate-specific differences in transporter/substrate translocation or re
lease. These novel data indicate that the insulin-sensitive transporter GLU
T4 transports DHA in both rat adipocytes and Xenopus oocytes, Alterations o
f this mechanism in diabetes could have clinical implications for ascorbate
utilization.